Chapter Seven - Chemo, Radiation, and the “Standard of Care”

CHAPTER SEVEN

Chemo, Radiation, and the “Standard of Care”

IF YOU’RE DIAGNOSED with cancer, odds are you’ll be given a plan.
That plan will follow a framework.
And that framework has a name: the standard of care.

It sounds reassuring. It sounds official.
But here’s what it really means:

“This is the treatment we’re allowed to give you without getting sued.”

The standard of care isn’t always the best option.
It’s the legally accepted one.
The insured one.
The coded and reimbursable one.

And at the center of that standard, even after decades of progress, are two medieval sledgehammers: chemotherapy and radiation.

Most traditional chemo isn’t subtle or targeted.

It’s a full-body assault on fast-growing cells.
And cancer cells tend to grow fast.

So do your hair follicles.
Your digestive lining.
Your bone marrow.

Which is why the most famous side effects of chemo like hair loss, vomiting, and immune suppression aren’t “side effects” at all. They’re on-target collateral damage. The treatment is very much so working. It’s just killing other things too.

Some chemos work better than others. Some are more specific.
But the basic idea is the same:
Drop a bomb and hope the cancer dies before the patient’s normal cells do.

And for many cancers, it does work.
At least in the short term.

But chemo also creates a new problem for survivors, cancer cells that can withstand the poison. The ones left behind are stronger. Smarter. Resistant. Ready to rebuild.

Which is why recurrence is so common.
And why second rounds are often harsher, both in toxicity and in diminishing returns.

Radiation therapy aims beams of high-energy particles at tumors.
The goal is to damage the DNA so badly the cancer cell dies.

It’s more localized than chemo. More controlled.
But it’s still a blunt instrument.

If the tumor is near something critical like the spine, the lungs, or the brain the risk of collateral damage skyrockets.
Radiation can cause scarring. It can damage nerves. It can trigger secondary cancers years later. And once tissue is radiated, it doesn’t heal the same way again.

It’s not a laser scalpel.
It’s a flamethrower you aim carefully.

And sometimes, it works beautifully.
But other times, it doesn’t, or it causes new problems down the line.

So why are these still the default?

Because they’re established.

They’ve been around for decades. They’ve been studied, standardized, codified, and insured.
They’re the safest path for hospitals, even when they’re not the safest path for patients.

Try suggesting something outside the protocol like nutrition, psychedelic-assisted therapies, alternative adjuncts, off-label immunotherapies, or anything unorthodox and you’ll be met with a wall of “not FDA-approved,” “not supported by randomized trials,” and “not covered by insurance.”

Meanwhile, if you walk into a hospital with stage 3 cancer, they’ll schedule chemo within the week.

Because that’s the protocol.
That’s the path of least liability.

Doctors are boxed in. The system punishes deviation and rewards adherence.

Even if the patient in front of them doesn’t fit the mold.

And this is where the tragedy sets in.

We’re still treating most cancers with the same old tools, even when the tumors themselves are wildly different.
Same diagnosis. Same playbook. Same three hammers: cut, poison, burn.

Never mind the individual. Never mind the tumor’s unique genetic fingerprint.
Never mind the immune system, the environment, and the psychology.

The standard of care doesn’t ask, “What’s best for this person?”
It asks, “What’s safest for us to recommend?”

And for a half-trillion-dollar industry, that’s a question with only a few acceptable answers.